Affiliation:
1. Shaanxi Institute for Food and Drug Control, China
2. Ninth Hospital of XI'an, China
Abstract
Abstract Lower respiratory tract infections (LRTIs) caused by Pseudomonas aeruginosa are the most common infection among hospitalized patients, associated with increased levels of morbidity, mortality and attributable health care costs. Increased resistant Pseudomonas worldwide has been quite meaningful to patients, especially in intensive care unit (ICUs). Different species of Pseudomonas exhibit different genetic profile and varied drug resistance. The present study determines the molecular epidemiology through DNA fingerprinting method and drug resistance of P. aeruginosa isolated from patients with LTRIs admitted in ICU. A total of 79 P. aeruginosa isolated from patients with LRTIs admitted in ICU were characterized by Restriction Fragment Length Polymorphism (RFLP), Random Amplified Polymorphic DNA (RAPD) and Repetitive Extrapalindromic PCR (REP-PCR). Antibiotic resistance was determined by minimum inhibitory concentration (MIC) assay while MDR genes, viz, blaTEM, blaOXA, blaVIM, blaCTX-M-15 were detected by polymerase chain reaction (PCR). Of the 137 Pseudomonas sp isolated from ICU patients, 57.7% of the isolates were reported to be P. aeruginosa. The overall prevalence of P. aeruginosa among the all included patients was 34.5%. The RAPD analysis yielded 45 different patterns with 72 clusters with 57% to 100% similarity level. The RFLP analysis yielded 8 different patterns with 14 clusters with 76% to 100% similarity level. The REP PCR analysis yielded 37 different patterns with 65 clusters with 56% to 100% similarity level. There was no correlation among the different DNA patterns observed between the three different methods. Predominant of the isolates (46.8%) were resistant to amikacin. Of the 79 isolates, 60.8% were positive for blaTEM gene and 39.2% were positive for blaOXA gene. P. aeruginosa was predominantly isolated from patients with LRTIs admitted in ICU. The difference in the similarity level observed between the three DNA fingerprinting methods indicates that there is high inter-strain variability. The high genetic variability and resistance patterns indicates that we should continuously monitor the trend in the prevalence and antibiotic resistance of P. aeruginosa especially in patients with LRTIs admitted in ICU.
Subject
General Agricultural and Biological Sciences
Reference40 articles.
1. The emergence of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis patients on inhaled antibiotics;ABDULWAHAB A.;Lung India : Official Organ of Indian Chest Society,2017
2. Microbiological study of lower respiratory tract infections in ICU patients;AGRAWAL G.N.;International Journal of Current Microbiology and Applied Sciences,2014
3. Lower Respiratory Tract Infections (LTRIs): an insight into the prevalence and the antibiogram of the gram negative, respiratory, bacterial agents;AHMED S.M.;Journal of Clinical and Diagnostic Research,2013
4. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study;ALBERTI C.;Intensive Care Medicine,2002
5. Detection rate of metallo-β-lactamase-expressing genes; blaVIM-1, blaVIM-2 and blaSPM-1 in Pseudomonas aeruginosa isolates;AMINI K.;International Journal of Basic Science in Medicine,2017
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献